Crossmark

Effectiveness and safety of transarterial chemoembolization combined with PD-1 inhibitors and lenvatinib for unresectable intrahepatic cholangiocarcinoma

Crossref DOI link: https://doi.org/10.1186/s41747-025-00563-4

Published Online: 2025-02-18

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Huang, Jin-Tao

Hu, Di

Hong, Xin

Zhou, Wen-Jie

Shen, Jian

Lv, Peng-Hua

Zhu, Xiao-Li https://orcid.org/0000-0003-0998-0124
Funding

Funding for this research was provided by:

the Key R&D Program (Social Development) Project of Jiangsu Province (BE2021648)
License Information

Text and Data Mining valid from 2025-02-18

Version of Record valid from 2025-02-18
More Information

Article History

Received: 14 September 2024

Accepted: 24 January 2025

First Online: 18 February 2025

Declarations

:

: The Institutional Ethics Review Board of the First Affiliated Hospital of Soochow University approved the study (date: 2024.07.10, no. 2024-361). Written informed consent was waived by the Institutional Review Board due to the retrospective nature of this study.

: Not applicable.

: The authors declare that they have no competing interests.

Document is current

Any future updates will be listed below